At a glance
ClinicalIndex Comparison Record- ✓Type 2 diabetes mellitus diagnosis
- ✓Body mass index 25-39.9 kg/m²
- ✓Able to give consent
- ✓Companion/team support partner must be available and committed to supporting achievement of goals
- ✕History of cancer or other serious comorbidity
- ✕Current pharmacotherapy for weight loss or corticosteroid use
- ✕Pregnancy
- ✕Blindness, amputation, foot ulcer, or dialysis dependence
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Feasibility Study on the Impact of Economic Incentives for Weight Loss to Improve the Management of Type 2 Diabetes Mellitus: REDEEM Feasibility Study
In Brief
A clinical study evaluating Diabetes education, Goal setting, and 3 other interventions for Diabetes Mellitus, Type 2. Completed, enrolled 54 participants across 1 site.
Detailed Summary
This feasibility study aims to compare the implementation process of three different interventions that use economic incentives to promote lifestyle behavioral changes in patients with type 2 diabetes mellitus, and to identify barriers and facilitators linked to the process of implementing each of the interventions. The interventions are based on economic incentives directed to the patient (individual incentives) or a team comprised by the patient and a partner (mixed incentives). Design: Three-month randomized control feasibility study to test the feasibility of implementing three types of intervention with economic incentives in patients with diabetes mellitus. Setting: Diabetes outpatient clinics from a public hospital in Peru.
Study Details
Timeline
Interventions
Participants interact with a diabetes educator (DE), every two weeks.
Goals for weight loss and change in levels of HbA1c
Patient has a companion/team support partner to support achieving goals.
The cash reward is given to the patient with diabetes.
Patients with diabetes and their companion support will each receive 50% of the cash reward.